Congratulations to our client, RoslinCT, who entered into a business combination agreement with Lykan Bioscience, the US based innovative CDMO focused on cell-based therapies. RoslinCT, a portfolio company of GHO Capital Partners LLP, and Lykan Bioscience, a portfolio company of WindRose Health Investors, combine to create a leading global advanced cell therapy CDMO. https://bit.ly/3JxMrU4 #AMon #DueDiligence #GlobalCDMO #Bioscience #CellTherapies
Suryanarayanan Namboodiri’s Post
More Relevant Posts
-
Congratulations to our client, Aspire Pharma Ltd (a portfolio company of H.I.G. Capital), on the acquisition of Cenote Pharma, a category specialist in carnitine deficiencies - strengthening its specialty pharma offering. https://bit.ly/3wR27zr #AMon #DueDiligence #Healthcare #Pharma
-
-
Looking forward to a busier 2024!!
A&M’s EMEA teams performed Due Diligence on +900 transactions in 2023, servicing clients across multiple sectors and industries. These projects cover Financial, Commercial, Regulatory, Operational, IT and Tax Due Diligence, demonstrating the breadth and depth of A&M’s service. We provide our clients a hands-on, conflict free offering. In 2024, we continue to support our clients with action-oriented, results-driven leadership. To learn more about A&M’s offering, click here: https://okt.to/K2r4Dc #AMon #PrivateEquity #DueDiligence
-
A short insightful read on M&A activity in healthcare!
Last year saw pharma M&A settle down into a slower pace as a result of macroeconomic uncertainty, rising interest rates and volatile capital markets, a trend that has continued into 2023. However this wider slowdown only tells one part of the story. Learn what verticals are driving M&A activity in the Healthcare space in A&M’s latest article here >> https://okt.to/mx81Gt #AMon #Healthcare #Pharma #CDMO #MandA
CDMOs, Specialty Pharma Among Verticals Driving M&A Activity in Healthcare
alvarezandmarsal.com
-
We have been shortlisted again this year and would welcome your support in clinching the win! Please do vote for A&M!
A&M has been shortlisted in the Unquote British Private Equity Awards for Financial Due Diligence Provider of the Year! Please kindly vote for us here https://okt.to/UPch6q #AMon #Vote #FinancialDueDiligence #PrivateEquity
Financial Due Diligence Provider of the Year
community.ionanalytics.com
-
A&M Transaction Advisory opens doors in Australia! Due diligence down under!
Alvarez & Marsal’s Global Transaction Advisory Group (TAG) expands its services and presence into Australia with the appointment of five Managing Directors, all formally with KPMG. This latest milestone of Global TAG’s strategic growth plan underscores the firm’s continued commitment to integrating its private equity (PE) services and operations capabilities across the Australia and New Zealand region. Read the full press release here: https://bddy.me/45sAOYi #AMon #TransactionAdvisory Paul Aversano, Anthony Caporrino, Xuong Liu, Fabio G. Pires, Jonathan Gibbons, Bhavik Hathi, Philip Mitchell, Stella Yuan, Scott Foster, David Willis, Vivian Santora, Victoria Whitman, Alison Fink, Doug Houston, David Savage, Steven Shirtliff, Mark Schiavello
Alvarez & Marsal's Global Transaction Advisory Group Expands in Australia Adding Five Managing Directors
alvarezandmarsal.com
-
Suryanarayanan Namboodiri reposted this
A&M recently presented a report looking at the future of the CDMO industry at the European Pharma Supply Chain and Logistics Innovation Programme in Basel, Switzerland. A survey was taken to capture what the audience thought was the most important growth strategy that Pharma Contract Development and Manufacturing Organizations (CDMOs) should consider for 2030. Please find the results below and learn more in our recent report on CDMO predictions for 2030: https://bddy.me/42YHAmQ To find out more, reach out to Lee Feander or Jan Diederichsen. #AMon #CDMO #Pharma #Growth #ValueChain
-
Another win!!
A&M’s EMEA Transaction Advisory Group won the Financial Due Diligence Provider of the year at the RealDeals Private Equity Awards 2023. Congratulations to the team, and to all other winners on the evening! https://bddy.me/3N1DSo4 #AMon #FinancialDueDiligence #TransactionAdvisory #PrivateEquity
Winners | Private Equity Awards 2022
privateequityawards.com
-
2022 was a busy year!!
A&M’s EMEA teams performed Due Diligence on +1000 transactions in 2022, servicing clients across multiple sectors and industries. These projects cover Financial, Commercial, Regulatory, Operational, IT and Tax Due Diligence, demonstrating the breadth and depth of A&M’s service. We provide our clients a hands-on, conflict free offering. In 2023, we continue to support our clients with action-oriented, results-driven leadership. To learn more about A&M’s offering, click here: https://bddy.me/3MbmWek #AMon #PrivateEquity #DueDiligence
A&M EMEA
alvarezandmarsal.com
